Drug intelligence / Profile preview

Iron protein succinylate

Development stage
Phase 4
Lead developer
Italfarmaco
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Administration
Oral
01

Overview

Iron protein succinylate is an oral iron supplement used to treat and prevent iron deficiency anemia. It consists of ferric (Fe3+) iron bound to a chemically modified (succinylated) casein protein, forming a stable complex that remains insoluble in the acidic environment of the stomach, thereby reducing gastrointestinal irritation. The complex releases ferric ions in the neutral-to-alkaline pH of the duodenum and proximal jejunum, where absorption occurs. After enzymatic digestion, soluble ferric species are released and reduced at the mucosal surface to ferrous (Fe2+) form for transport into enterocytes. This formulation provides gradual and sustained elevation of serum iron levels with improved tolerability compared to traditional ferrous salts, leading to fewer gastrointestinal side effects and shorter treatment duration for anemia[1][3][5][6]. Iron protein succinylate is primarily indicated for treating iron deficiency anemia.

Brand names
Ferretts IPS
Other names
iron succinyl-protein complexferric iron complex of succinylated protein

Beyond the preview

Go deeper on Iron protein succinylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron protein succinylate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call